Skip to content
News
Press Releases
News Clips
Media Contacts
Get Our Newsletters
Events
Events
Presentations
Publications
Publication Types
Reports & Briefings
Commentary
Testimonies & Filings
Books & Edited Volumes
Knowledge Bases
Podcasts
Issue Areas
Clean Energy
Innovation & Competitiveness
IT & Data
Life Sciences
Broadband & Spectrum
Trade & Globalization
Regions
Africa
Asia-Pacific
Canada
China
Europe
Global
Latin America
United Kingdom
Centers
Aegis Project for Defending U.S. Tech Leadership
Center for Clean Energy Innovation
Center for Data Innovation
Center for Life Sciences Innovation
Center for Korean Innovation and Competitiveness
Centre for Canadian Innovation and Competitiveness
Hamilton Center on Industrial Strategy
Schumpeter Project on Competition Policy
About
About ITIF
Staff
Board
Affiliated Experts
Supporters
Jobs
Donate
Op-Art: Drug Price Controls vs. the NIH “Cancer Moonshot” Initiative
By
Robert D. Atkinson
|
February 21, 2022
Editors’ Recommendations
September 9, 2019
The Link Between Drug Prices and Research on the Next Generation of Cures
November 22, 2021
Drug Price Controls Are Bad Policy. Congress Should Instead Double Down on Innovation to Boost Productivity in Biopharma R&D
May 20, 2021
Five Fatal Flaws in Rep. Katie Porter’s Indictment of the U.S. Drug Industry
